Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | OR502 |
Trade Name | |
Synonyms | OR 502|OR-502 |
Drug Descriptions |
OR502 is an anti-LILRB2 antibody, which interferes with binding of LILRB2 to HLA class I molecules and potentially enhances antitumor immune response (Journal for ImmunoTherapy of Cancer 2023;11). |
DrugClasses | LILRB2 Antibody 11 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cemiplimab + OR502 | Cemiplimab OR502 | 0 | 1 |
OR502 | OR502 | 0 | 0 |